Skip to main content
Fig. 2 | World Journal of Surgical Oncology

Fig. 2

From: Proline-rich protein 11 overexpression is associated with a more aggressive phenotype and poor overall survival in ovarian cancer patients

Fig. 2

Kaplan-Meier curves of overall survival in patients with OC according to the expression of PRR11. a Patients with positive expression of PRR11 presented shorter overall survival (OS) duration than those patients negative for PRR11 protein expression (6.0 years versus 3.25 years, P < 0.001). b Subgroup analysis according to the FIGO tumor staging criteria showing that PRR11-positive patients at stages I/II present an unfavorable prognosis (median OS: 5.5 years) compared with PRR11-negative patients at stages I/II (median OS: 7.75 years, P = 0.30). c PRR11-positive patients at stages III/IV showed an extremely unfavorable prognosis (median OS: 2.5 years) compared with PRR11-negative patients at stage III/IV (median OS: 5.0 years, P < 0.001)

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us